Stephen B. Hanauer, MD - Progress in Understanding the Pathogenesis of IBD and Development of Individualized Therapy: What Does the Latest Evidence Show?

Summary: In this activity, an expert in gastroenterology discusses the current perspectives and latest advances in the understanding of the etiology and pathogenesis of inflammatory bowel disease (IBD) and how the improved knowledge of the underlying biology has lead to the development of rational, targeted therapies. The appropriate use and positioning of the standard and novel biologic therapies in the overall management of Crohn's disease and ulcerative colitis are summarized, and emerging targeted therapies showing promise in the treatment of these diseases are highlighted as well.